Focus
Astrazeneca
AstraZeneca Capping Inhaler Costs for Eligible Customers at $35 From June 1
The new cap will apply to AstraZeneca’s entire range of inhaler products including Symbicort, Breztri Aerosphere, and Airsupra inhalers.
Judge Dismisses AstraZeneca’s Challenge to Medicare Drug Price Negotiation
The judge emphasizes that AstraZeneca’s participation in the Medicare program is ‘a voluntary undertaking.’
Biden Administration Begins Medicare Drug Price Negotiations
President Biden’s bid to lower drug prices, coming ahead of November’s election, has led to accusations of him trying to win ‘political points.’
AstraZeneca to Acquire Chinese Firm to Boost Cell Therapy Portfolio
An analyst said the proposed acquisition of Gracell ould be AstraZeneca’s way of getting more into cell therapy.
Actress Sues AstraZeneca, Alleging COVID-19 Jab Left Her With Brain Injuries
Melle Stewart was a hugely successful actress. Now she has a piece of titanium the size of her hand lodged in her skull.
Class Action Lawsuit Against AstraZeneca for Vaccine Injury Moves Forward
Pharmaceuticals giant says ‘benefits of vaccination outweigh the risks of extremely rare potential side effects.’
Major Countries Officially Report 100 Deaths Caused by COVID-19 Vaccines
Concerns about side effects and under-researched adverse events have prompted nations around the world to call for the suspension of the COVID-19 vaccine.
